By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

CeQur SA 

Rue Igor-Stravinsky 2
Case Postale 341
Montreux    1820  Switzerland
Phone: 41-21-9654646 Fax: n/a


SEARCH JOBS


Industry
Biotechnology






Company News
CeQur SA Appoints Douglas Lawrence Chief Executive Officer 4/10/2014 9:59:41 AM
CeQur SA Release: Diabetes Care Publishes Data Demonstrating PaQ® Insulin Delivery Device Could Help People With Type 2 Diabetes Overcome Barriers To Insulin Adherence And Improve Clinical Outcomes 3/5/2014 10:08:44 AM
CeQur SA To Present At The 32nd Annual J.P. Morgan Healthcare Conference 1/8/2014 7:12:33 AM
CeQur SA Closes $27 Million Series B Financing 9/9/2013 7:05:54 AM
CeQur SA Release: New Data Demonstrate Simple Insulin Delivery Device Can Significantly Reduce Barriers to Insulin Treatment Among People With Type 2 Diabetes 6/24/2013 10:30:32 AM
Positive Results for CeQur SA's PaQ® Insulin Delivery Device 3/1/2013 6:57:45 AM
CeQur SA Announces Positive Results From Study Evaluating Simple Insulin Delivery Device Among People With Type 2 Diabetes 2/28/2013 11:30:15 AM
CeQur SA Appoints Michael Trautmann, MD Medical Director for Anti-Diabetic Peptides 12/11/2012 9:41:25 AM
CeQur SA Receives CE Mark for PaQ® Insulin Delivery Device 11/27/2012 8:13:48 AM
CeQur SA Completes Study Evaluating Ability of Simple Insulin Delivery Device to Replace Insulin Injections Among People With Type 2 Diabetes 9/26/2012 10:09:25 AM
12
//-->